Toth Financial Advisory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Toth Financial Advisory's GILD Position: Q2 2026 in Review
Toth Financial Advisory reduced its Gilead Sciences (GILD) stake by 8.6% in Q2 2026, selling an estimated $1.45K and leaving 117 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #542.
Toth Financial Advisory first reported a position in GILD in Q4 2017 and has held it in 25 quarters since. The position peaked at $40K in Q2 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Toth Financial Advisory held 117 shares of Gilead Sciences worth $14.8K as of Q2 2026.
- Toth Financial Advisory sold 11 Gilead Sciences shares in Q2 2026, an estimated $1.45K.
- Gilead Sciences made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #542 holding.
- Toth Financial Advisory first reported a position in Gilead Sciences in Q4 2017 and has held it in 25 quarters since.
- Toth Financial Advisory's Gilead Sciences position peaked at $40K in Q2 2020.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.